Clarity Pharmaceuticals Ltd (ASX: CU6)
Health Care · Pharmaceuticals · AU
AU$2.10
-0.47% today · -59.1% 1Y
Clarity Pharmaceuticals Ltd (ASX: CU6) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $544.53M and employs 100 people.
Over the last twelve months the share price has lost 59.1%, trading between 1.80 and 5.87.
Tweenvest scores Clarity Pharmaceuticals Ltd across four factors: quality 36/100, value 37/100. Its strongest factor is value.
CU6 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $544.53M
- Revenue (TTM)
- $7.28M
- P/E
- —
- EPS
- -0.29
- Dividend yield
- —
- Beta (5Y)
- 1.18
- 52-week high
- AU$5.87
- 52-week low
- AU$1.80
- Avg volume (3M)
- —
- Shares outstanding
- 373.08M
- Employees
- 100
- Next earnings
- —
About Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
- ISIN
- AU0000165375
- Founded
- 2010
- Listed since
- Aug 25, 2021
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| GlaxoSmithKline S.A.ECASE: BIOC | $558.53M | EGP350.11 | +36.94% |
| Nanjing Hicin Pharmaceutical Co., Ltd.SZSE: 300584 | $557.80M | CN¥31.18 | +3.11% |
| Zhuhai Rundu Pharmaceutical Co., Ltd.SZSE: 002923 | $550.68M | CN¥11.03 | +1.66% |
| Phathom Pharmaceuticals, Inc.NasdaqGS: PHAT | $549.66M | $7.13 | +3.03% |
| Komipharm International Co., Ltd.KOSDAQ: A041960 | $530.71M | ₩9,880.00 | +0.30% |
| Zeria Pharmaceutical Co., Ltd.TSE: 4559 | $530.44M | ¥1,898.00 | -6.73% |
| Ocumension TherapeuticsSEHK: 1477 | $529.93M | HK$5.10 | -2.76% |
| Boryung CorporationKOSE: A003850 | $525.96M | ₩8,420.00 | +1.69% |
Figures last refreshed Oct 4, 2026.